Intraocular implant, kit, and implantation method
Patent Information
- Application Number
- JP2025501457
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2022-07-12
- Filing Date
- 2023-07-10
- Publication Date
- 2026-07-13
AI Technical Summary
Existing glaucoma treatments, including medication, laser surgery, and minimally invasive implants, face challenges such as patient non-compliance, complications, and implant blockage due to fibrosis, particularly in the suprachoroidal space, leading to endothelial cell loss and instability.
An intraocular implant with an arched elongated frame is designed for placement in the suprachoroidal space, featuring a resilient shape, non-linear edge profiles, and a network of interconnected arms to enhance positional stability, reduce longitudinal movement, and promote aqueous humor drainage.
The implant provides high positional stability, reduces the risk of endothelial cell loss, and minimizes the need for protrusion, thereby enhancing the longevity and reliability of the treatment by anchoring effectively within the suprachoroidal space.
Smart Images

Figure 00000000_0000_ABST
